| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |